NHS Supply Chain has demonstrated how Value Based Procurement can significantly improve patient outcomes and reduce systemwide costs through a pioneering programme evaluating second-generation surgical mesh.
Around 100,000 hernia repairs take place each year in England, with Complex Abdominal Wall Reconstruction (CAWR) patients historically facing high recurrence rates. The most commonly used biologic meshes often degrade over time, leading to repeat surgeries, long recoveries and increasing pressure on NHS resources.
After a new ovine collagen second-generation mesh showed early promise several years ago, NHS Supply Chain worked closely with University Hospitals of Morecambe Bay to understand the root causes of recurrence and evaluate the new mesh in real world settings.
The results have been transformative. Grade 3 patients – who represent the most complex cases – previously experienced an 80% recurrence rate over three years with BADM (Bovine Acellular Dermal Matrix) meshes; with the new mesh, recurrence dropped to 0.8% across 120 cases, resulting in shorter hospital stays and fewer complications.
These improvements drove a 50% reduction in pathway costs over a year, generating £1.57 million in productivity and efficiency savings for the trust.
Mr Paul Wilson, MB, ChB (Hons), FRCS Ed, FRCS (Gen) Consultant in General, Laparoscopic and Abdominal Wall Reconstruction Surgery, University Hospitals of Morecambe Bay, said: "Our reconstructions over the last three and a half years have demonstrated excellent clinical outcomes and significantly lower recurrence and complication rates vs our BADM series."
Ian Dodd, Clinical Engagement and Implementation Manager at NHS Supply Chain, added: "This pioneering collaboration between NHS Supply Chain, leading NHS clinicians and innovative suppliers has delivered a game changing solution. Durable, culturally acceptable surgical mesh technologies are significantly improving patient outcomes while reducing unnecessary clinical interventions and freeing up valuable NHS resources."
NHS Supply Chain’s value-based approach, supported by robust financial validation, strong clinical leadership and detailed pathway analysis, has given confidence to trusts across England and Wales to adopt this redesigned pathway.
Following the success of the pilot, NHS Supply Chain has identified further trusts to partner with, scaling the second-generation mesh initiative nationally.
For more information, visit: https://www.supplychain.nhs.uk/news-article/value-based-procurement-surgical-mesh/
